Males, Sylvia <br/><br/>
Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C.  [electronic resource] 

 -  Antiviral therapy  2007 
 - 797-803 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1359-6535 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Biomarkers--blood<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Egypt<br/>Female<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Patient Selection<br/>Polyethylene Glycols--administration & dosage<br/>Proteins--metabolism<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load<br/>Virus Replication--drug effects<br/>alpha-Fetoproteins